Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree

Annals of Hepatology

Volumn 10, Issue 3, 2011, Pages 349-354

  Wijlemans, Joost W ^a   van Erpecum, Karel J ^a   Lam, Marnix G E H ^a   Seinstra, Beatrijs A ^a   Smits, Maarten L J ^a   Zonnenberg, Bernard A ^a   van den Bosch, Maurice A A J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Gallbladder carcinoma; Intrahepatic cholangiocarcinoma

Indexed keywords

ALKALINE PHOSPHATASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; MACROSALB TC 99M; MICROSPHERE; SIR SPHERES; THERASPHERES; UNCLASSIFIED DRUG; YTTRIUM 90;

ADENOCARCINOMA; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BILIRUBIN BLOOD LEVEL; CANCER INFILTRATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FATIGUE; GALLBLADDER CARCINOMA; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEPATIC ARTERY; HUMAN; INOPERABLE CANCER; INTRAHEPATIC CHOLANGIOCARCINOMA; JAUNDICE; LIVER BIOPSY; LIVER CARCINOMA; LIVER METASTASIS; LIVER PARENCHYMA; LUNG SHUNTING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OFF LABEL DRUG USE; PROGNOSIS; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RADIATION DOSE; SAFETY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRANSARTERIAL RADIOEMBOLIZATION; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VOLUME; WEIGHT REDUCTION;

EID: 79959423172     PISSN: 16652681     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1665-2681(19)31549-2     Document Type: Article

References (25)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-14.
2. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-76.
3. Ortner MA. Photodynamic therapy for cholangiocarcinoma: Overview and new developments. Current Opinion in Gastroenterol 2009; 25: 472-6.
4. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, Thillainayagam AV, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: Consensus document. Gut 2002; 51(Suppl. 6):VI1-VI9.
5. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Seminars in Liver Dis 2004; 24: 115-25.
6. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15: 4240-62.
7. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillmoe KD, Choti MA, et al. Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution. Ann Surg 2007; 245: 755-62.
8. Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. Gallbladder cancer. Am J Surg 2008; 196: 252-64.
9. Nehls O, Klump B, Arkenau HT, Hass HG, Greschniok A, Gregor M, Porschen R. Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: A prospective phase II trial. British J Cancer 2002; 87: 702-4.
10. Papakostas P, Kouroussis C, Androulakis N, Samelis G, Aravantinos G, Kalbakis K, Sarra E, et al. First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study. European J Cancer 2001; 37: 1833-8.
11. Shinohara ET, Mitra N, Guo M, Metz JM. Radiation therapy is associated with improved survival in the adjuvant and definitive treatment of intrahepatic cholangiocarcinoma. International J Radiation Oncol, Biol, Physics 2008; 72: 1495-501.
12. Houry S, Haccart V, Huguier M, Schlienger M. Gallbladder cancer: role of radiation therapy. Hepatogastroenterology 1999; 46: 1578-84.
13. Abu-Hamda EM, Baron TH. Endoscopic management of cholangiocarcinoma. Seminars in Liver Dis 2004; 24: 165-75.
14. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-76.
15. Bilbao JI, Reiser MF. Liver radioembolization with Y-90 microspheres. Berlin: Heidelberg; 2008.
16. Buscombe JR. Interventional nuclear medicine in hepatocellular carcinoma and other tumours. Nuclear Med Communications 2002; 23: 837-41.
17. Aliberti C, Benea G, Tilli M, Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: Preliminary results. Cardiovasc and Intervent Radiol 2008; 31: 883-8.
18. Gusani NJ, Balaa FK, Steel JL, Geller DA, Marsh JW, Zajko AB, Carr BI, et al. Treatment of unresectable cholangiocarcinoma with gemcitabine-based transcatheter arterial chemoembolization (TACE): A single-institution experience. J Gastrointestinal Surg 2008; 12: 129-37.
19. Burger I, Hong K, Schulick R, Georgiades C, Thuluvath P, Choti M, Kamel I, et al. Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: Initial experience in a single institution. J Vasc Intervent Radiol 2005; 16: 353-61.
20. Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, van het Schip AD, et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: A structured meta-analysis. European Radiol 2009; 19: 951-9.
21. Salem R, Thurston KG. Radioembolization with yttrium-90 microspheres: A state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: Part 3: Comprehensive literature review and future direction. J Vasc Intervent Radiol 2006; 17: 1571-93.
22. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Dancey J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European J Cancer 2009; 45: 228-47.
23. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatology 2001; 35: 421-30.
24. Saxena A, Bester L, Chua TC, Chu FC, Morris DL. Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: A preliminary assessment of this novel treatment option. Ann Surg Oncol 2010; 17: 484-91.
25. Ibrahim SM, Mulcahy MF, Lewandowski RJ, Sato KT, Ryu RK, Masterson EJ, Newman SB, et al. Treatment of unresectable cholangiocarcinoma using yttrium-90 microspheres: Results from a pilot study. Cancer 2008; 113: 2119-28.